Eligen B12™
Eligen B12™ is a once-daily oral non-prescription medical food, which normalises B12 levels without injection.
Beovu® (Brolucizumab) for the Treatment of wet Age-related Macular Degeneration (AMD)
Brolucizumab was approved based on the outcome of HAWK and HARRIER phase three studies. Credit: Novartis.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
KPS
Founded in 2010, KPS is a Functional Service Provider (FSP)...
About
Founded in 2010, KPS is a Functional Service Provider (FSP) offering Clinical Monitoring, Project Management and CRO Oversight solutions to the biopharmaceutical industry.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
Emisphere Technologies
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced...
About
Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.
FollowMake an Enquiry